Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lutetium lu-177 vipivotide tetraxetan
Drug ID BADD_D02567
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID C000610110
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code Not Available
UNII G6UF363ECX
Synonyms 177Lu-PSMA-617 | 177Lu-617-prostate-specific membrane antigen ligand
Chemical Information
Molecular Formula Not Available
CAS Registry Number Not Available
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaemia01.03.02.001-
Bone pain15.02.01.001-
Cholestasis09.01.01.001-Not Available
Death08.04.01.001-
Dry mouth07.06.01.002-
Pancytopenia01.03.03.003-Not Available
Prostate cancer metastatic21.04.02.004; 16.25.01.002-Not Available
Thrombocytopenia01.08.01.002-Not Available
General physical health deterioration08.01.03.018-Not Available
Malignant neoplasm progression16.16.01.005-Not Available
Prostate cancer16.25.01.001; 21.04.02.002-Not Available
Inflammation10.02.01.089; 08.01.05.007-Not Available
Ill-defined disorder08.01.03.049-Not Available
Disease progression08.01.03.038-
Cytopenia01.03.03.012-Not Available
Metastases to bone16.22.02.005; 15.09.03.006-Not Available
Hormone-refractory prostate cancer21.04.02.007; 16.25.01.004-Not Available
Illness08.01.03.091-Not Available
Myelosuppression01.03.03.015-Not Available
The 1th Page    1    Total 1 Pages